Skip to menu Skip to content Skip to footer
Dr Matthew Roberts
Dr

Matthew Roberts

Email: 
Phone: 
+61 7 334 66047

Overview

Background

Matthew J. Roberts, BSc, MBBS, PhD, FRACS (Urol)

  • Consultant Urologist, Royal Brisbane and Women’s (RBWH), Surgical Treatment and Rehabilitation Service (STARS), Queensland Health
  • Clinician Research Fellow, Metro North Hospital and Health Service
  • Group Leader & Associate Professor, The University of Queensland Centre for Clinical Research

Matthew is a medical graduate of The University of Queensland and completed Urology specialty training in Queensland and New South Wales. He completed his PhD under the supervision of Professor “Frank” Gardiner investigating new biomarkers for the early detection and characterization of prostate cancer.

Matthew is a surgeon-scientist, working clinically as a urologist and robotic surgeon at RBWH & STARS with academic appointment as Clinician Research Fellow at Metro North Health (Qld) and Associate Professor at UQCCR. His clinical and research interests are in Urologic cancers (e.g. prostate cancer), focusing on novel imaging and biomarkers, clinical trials, urological infections and innovation in urology. He has authored over 140 peer reviewed manuscripts in international journals and presented research at more than 20 international urology and clinical cancer meetings. He is a member of the EAU Prostate Cancer Guidelines Committee, Prostate Cancer Outcomes Registry (PCOR)-Queensland Steering Committee, Editorial Board of the BJU International, as well as Co-Convenor of the ANZUP 2024 ASM.

Availability

Dr Matthew Roberts is:
Available for supervision

Qualifications

  • Bachelor of Biomedical Science, The University of Queensland
  • Bachelor of Medicine, The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Research interests

  • Urology

    All fields related to urology including urologic oncology, prostate cancer, kidney/renal cancer, bladder cancer and others. Urologic infections Quality-of-life and survivorship research Systematic review and meta-analysis.

Works

Search Professor Matthew Roberts’s works on UQ eSpace

247 works between 2000 and 2025

1 - 20 of 247 works

Featured

2020

Journal Article

Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution

Roberts, Matthew J., Macdonald, Alastair, Ranasinghe, Sachinka, Bennett, Harrison, Teloken, Patrick E., Harris, Patrick, Paterson, David, Coughlin, Geoff, Dunglison, Nigel, Esler, Rachel, Gardiner, Robert A., Elliott, Thomas, Gordon, Louisa and Yaxley, John (2020). Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution. Prostate Cancer and Prostatic Diseases, 24 (1), 169-176. doi: 10.1038/s41391-020-0263-x

Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution

Featured

2020

Journal Article

68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer

Roberts, Matthew J., Morton, Andrew, Donato, Peter, Kyle, Samuel, Pattison, David A., Thomas, Paul, Coughlin, Geoff, Esler, Rachel, Dunglison, Nigel, Gardiner, Robert A., Doi, Suhail A., Emmett, Louise and Yaxley, John (2020). 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 48 (2), 655-656. doi: 10.1007/s00259-020-04944-2

68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer

Featured

2019

Journal Article

Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane antigen-avid lesions: a systematic review and meta-analysis

Perera, Marlon, Papa, Nathan, Roberts, Matthew, Williams, Michael, Udovicich, Cristian, Vela, Ian, Christidis, Daniel, Bolton, Damien, Hofman, Michael S., Lawrentschuk, Nathan and Murphy, Declan G. (2019). Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane antigen-avid lesions: a systematic review and meta-analysis. European Urology, 77 (4), 403-417. doi: 10.1016/j.eururo.2019.01.049

Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane antigen-avid lesions: a systematic review and meta-analysis

Featured

2015

Journal Article

The emerging threat of multidrug-resistant Gram-negative bacteria in urology

Zowawi, Hosam M., Harris, Patrick N. A., Roberts, Matthew J., Tambyah, Paul A., Schembri, Mark A., Pezzani, M. Diletta, Williamson, Deborah A. and Paterson, David L. (2015). The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nature Reviews Urology, 12 (10), 570-584. doi: 10.1038/nrurol.2015.199

The emerging threat of multidrug-resistant Gram-negative bacteria in urology

Featured

2015

Journal Article

Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis

Perera, Marlon, Roberts, Matthew J., Doi, Suhail A. R. and Bolton, Damien (2015). Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. European Urology, 67 (4), 704-713. doi: 10.1016/j.eururo.2014.10.031

Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis

Featured

2015

Journal Article

Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer

Roberts, Matthew J., Chow, Clement W., Schirra, Horst J., Richards, Renee, Buck, Marion, Selth, Luke A., Doi, Suhail A. R., Samaratunga, Hema, Perry-Keene, Joanna, Payton, Diane, Yaxley, John, Lavin, Martin F. and Gardiner, Robert A. (2015). Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer. Prostate, 75 (5), 539-549. doi: 10.1002/pros.22942

Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer

Featured

2014

Journal Article

Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted meta-analysis

Roberts, Matthew J., Williamson, Deborah A., Hadway, Paul, Doi, Suhail A. R., Gardiner, Robert A. and Paterson, David L. (2014). Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted meta-analysis. International Journal of Antimicrobial Agents, 43 (4), 301-309. doi: 10.1016/j.ijantimicag.2014.01.008

Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted meta-analysis

2025

Journal Article

Clinically boosting cancer molecular targeted radioligand therapies with innovative nanomaterials

Koo, Kevin M., Lim, Malcom, Simpson, Peter, Lakhani, Sunil, Roberts, Matthew, Masud, Mostafa, Puttick, Simon and Rose, Stephen (2025). Clinically boosting cancer molecular targeted radioligand therapies with innovative nanomaterials. ChemNanoMat, 11 (1). doi: 10.1002/cnma.202400449

Clinically boosting cancer molecular targeted radioligand therapies with innovative nanomaterials

2024

Journal Article

Intra-individual comparisons of [18F]fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in prostate cancer patients across different disease states: new insights into disease heterogeneity

McGeorge, Stephen, Pattison, David A., Dhiantravan, Nattakorn, Thomas, Paul A., Yaxley, John W. and Roberts, Matthew J. (2024). Intra-individual comparisons of [18F]fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in prostate cancer patients across different disease states: new insights into disease heterogeneity. Uro, 5 (1), 1-11. doi: 10.3390/uro5010001

Intra-individual comparisons of [18F]fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in prostate cancer patients across different disease states: new insights into disease heterogeneity

2024

Journal Article

Improving clinical efficiency using retrieval‐augmented generation in urologic oncology: A guideline‐enhanced artificial intelligence approach

Collin, Harry, Roberts, Matthew J., Keogh, Kandice, Siriwardana, Amila and Basto, Marnique (2024). Improving clinical efficiency using retrieval‐augmented generation in urologic oncology: A guideline‐enhanced artificial intelligence approach. BJUI Compass. doi: 10.1002/bco2.427

Improving clinical efficiency using retrieval‐augmented generation in urologic oncology: A guideline‐enhanced artificial intelligence approach

2024

Journal Article

A pilot study of PSMA PET/CT and MRI fusion for prostate cancer: Software to replace PET/MRI hardware

Mehawed, Georges, Roberts, Matthew J., Bugeja, Jessica, Dowling, Jason, Stewart, Kate, Gunasena, Rivindi, Malczewski, Frances, Rukin, Nicholas J. and Murray, Rebecca (2024). A pilot study of PSMA PET/CT and MRI fusion for prostate cancer: Software to replace PET/MRI hardware. Journal of Clinical Medicine, 13 (23) 7384, 1-11. doi: 10.3390/jcm13237384

A pilot study of PSMA PET/CT and MRI fusion for prostate cancer: Software to replace PET/MRI hardware

2024

Journal Article

The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

Teppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew J., Fairbairn, David, Smith, David P., Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. Value in Health, 27 (11), 1515-1527. doi: 10.1016/j.jval.2024.06.019

The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

2024

Conference Publication

The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

Teppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew, Fairbairn, David, Smith, David, Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD Australia, 13–15 November 2024. Richmond, VIC Australia: John Wiley & Sons.

The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

2024

Journal Article

Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics

Roberts, Matthew J., Papa, Nathan, Veerman, Hans, de Bie, Katelijne, Morton, Andrew, Franklin, Anthony, Raveenthiran, Sheliyan, Yaxley, William J., Donswijk, Maarten L., van der Poel, Henk G., Samaratunga, Hemamali, Wong, David, Brown, Nicholas, Parkinson, Robert, Gianduzzo, Troy, Kua, Boon, Coughlin, Geoffrey D., Oprea‐Lager, Daniela E., Emmett, Louise, van Leeuwen, Pim J., Yaxley, John W. and Vis, André N. (2024). Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics. BJU International, 134 (S2), 47-55. doi: 10.1111/bju.16482

Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics

2024

Journal Article

The role of prostate-specific membrane antigen positron emission tomography/computed tomography in primary staging of selected renal tumours: initial experience in a multicentre cohort

Tariq, Arsalan, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Raveenthiran, Sheliyan, Pelecanos, Anita, Gan, Chun Loo, Goh, Jeffrey C., Wong, David, McBean, Rhiannon, Marsh, Phillip, Goodman, Steven, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John W., Thomas, Paul, Pattison, David A. and Roberts, Matthew J. (2024). The role of prostate-specific membrane antigen positron emission tomography/computed tomography in primary staging of selected renal tumours: initial experience in a multicentre cohort. European Urology Focus, 10 (5), 770-778. doi: 10.1016/j.euf.2023.12.004

The role of prostate-specific membrane antigen positron emission tomography/computed tomography in primary staging of selected renal tumours: initial experience in a multicentre cohort

2024

Journal Article

Cost-utility analysis of navigate, a treatment decision aid for men with prostate cancer and their partners, in comparison to usual care

Lindsay, Daniel, Schofield, Penelope, Roberts, Matthew J., Yaxley, John, Quinn, Stephen, Richards, Natalie, Frydenberg, Mark, Gardiner, Robert, Lawrentschuk, Nathan, Juraskova, Ilona, Murphy, Declan G. and Collins, Louisa G. (2024). Cost-utility analysis of navigate, a treatment decision aid for men with prostate cancer and their partners, in comparison to usual care. European Urology Oncology. doi: 10.1016/j.euo.2024.08.005

Cost-utility analysis of navigate, a treatment decision aid for men with prostate cancer and their partners, in comparison to usual care

2024

Journal Article

Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer

Emmett, Louise, Papa, Nathan, Hope, Thomas A., Fendler, Wolfgang, Calais, Jeremie, Burger, Irene, Eiber, Matthias, Barbato, Francesco, Moon, Daniel, Counter, William, John, Nikeith, Xue, Alan, Franklin, Anthony, Thompson, James, Rasiah, Kris, Frydenberg, Mark, Yaxley, John, Buteau, James, Agrawal, Shikha, Ho, Bao, Nguyen, Andrew, Liu, Victor, Lee, Jonathan, Woo, Henry, Hsiao, Edward, Sutherland, Thomas, Perry, Elyse, Stricker, Phillip, Hofman, Michael S. ... Murphy, Declan (2024). Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer. The Journal of urology, 212 (2), 299-309. doi: 10.1097/JU.0000000000004010

Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer

2024

Journal Article

ChatGPT can help guide and empower patients after prostate cancer diagnosis

Collin, Harry, Keogh, Kandice, Basto, Marnique, Loeb, Stacy and Roberts, Matthew J. (2024). ChatGPT can help guide and empower patients after prostate cancer diagnosis. Prostate Cancer and Prostatic Diseases, 1-3. doi: 10.1038/s41391-024-00864-6

ChatGPT can help guide and empower patients after prostate cancer diagnosis

2024

Journal Article

Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer

Buteau, James P., Moon, Daniel, Fahey, Michael T., Roberts, Matthew J., Thompson, James, Murphy, Declan G., Papa, Nathan, Mitchell, Catherine, De Abreu Lourenco, Richard, Dhillon, Haryana M., Kasivisvanathan, Veeru, Francis, Roslyn J., Stricker, Phillip, Agrawal, Shihka, O'Brien, Jonathan, McVey, Aoife, Sharma, Gaurav, Levy, Sidney, Ayati, Narjess, Nguyen, Andrew, Lee, Su-Faye, Pattison, David A., Sivaratnam, Dinesh, Frydenberg, Mark, Du, Yang, Titus, Jehan, Lee, Sze-Ting, Ischia, Joseph, Jack, Greg ... Emmett, Louise (2024). Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer. European Urology Oncology, 7 (3), 544-552. doi: 10.1016/j.euo.2023.11.008

Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer

2024

Journal Article

Determining the optimal fill volume for fluid‐filled testicular prostheses – less is more

Mehawed, Georges, Murray, Rebecca, Wang, Kevin, Roberts, Matthew J. and Rukin, Nicholas J. (2024). Determining the optimal fill volume for fluid‐filled testicular prostheses – less is more. BJU International, 134 (S2), 14-16. doi: 10.1111/bju.16374

Determining the optimal fill volume for fluid‐filled testicular prostheses – less is more

Funding

Current funding

  • 2024 - 2030
    Prostate Cancer - FDG - Spatial Imaging (Spatial biology meets PET imaging: A non-invasive, Google Map for Prostate cancer)
    PA Research Foundation
    Open grant
  • 2022 - 2025
    Randomized, Double-Blind, Placebo-controlled, Multicenter Phase 3 Study to Assess the Efficacy, Safety and Immunogenicity of Vaccination With ExPEC9V in the Prevention of Invasive Extraintestinal Path
    Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
    Open grant

Past funding

  • 2022 - 2023
    Prospective surgeon-led trials in Prostate Cancer for personalised management and healthcare sustainability
    Viertl Clinical Investigator Award
    Open grant
  • 2021 - 2022
    De-Intensification of Post ProstatEctomy Radiotherapy (DIPPER) incorporating clinical and imaging-based risk stratification: Part 1 - Pilot study (additional site)
    ANZUP Below the Belt Research Fund
    Open grant
  • 2021
    A prospective clinical evaluation of prostate biopsy under local anaesthetic to optimise health care resources: feasibility study
    Metro North Hospital and Health Service
    Open grant
  • 2021
    Staging of aggressive prostate cancer 'invisible' to PSMA-PET: The FDG-PET for INvisible Disease (FIND) Trial
    Metro North Hospital and Health Service
    Open grant
  • 2018
    Combined TMPRSS2:ERG, PCA3 and SChLAP1 RNA in Urine for selective detection of Aggressive Prostate Cancer
    Metro North Hospital and Health Service
    Open grant
  • 2015
    Exploring new Paradigms in Pre-prostate cancer detection and management
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2014 - 2016
    Exploring new Paradigms in Pre-prostate cancer detection and management
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2013
    Optimising collection for metabonomic profiling of ejaculate to complement PCR in prostate cancer detection
    Royal Brisbane and Women's Hospital
    Open grant

Supervision

Availability

Dr Matthew Roberts is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Roles of image fusion and 3D technology in urology: exploration and clinical integration for personalised devices

    Associate Advisor

    Other advisors: Professor Kristofer Thurecht, Dr Nick Rukin

Media

Enquiries

For media enquiries about Dr Matthew Roberts's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au